MedPath

AVL200 IOL for Treatment of Cataract and Presbyopia

Not Applicable
Recruiting
Conditions
Cataract
Registration Number
NCT05627700
Lead Sponsor
Atia Vision
Brief Summary

This study is to evaluate the performance of the AVL200 IOL in terms of visual function improvement over a range of focal points. Participants meeting eligibility criteria will undergo cataract surgery with implantation of the AVL200 intraocular lens (IOL), then be followed through 1 year postoperatively. Postoperative assessments include safety and visual function.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Visually significant cataract
  • Best corrected distance visual acuity between 20/40 and 20/200
  • Potential distance visual acuity of 20/32 or better
  • Corneal astigmatism ≤ 1.5 diopters
Exclusion Criteria
  • Use of medication that could affect accommodation
  • Previous corneal surgery or significant corneal abnormalities
  • Ocular pathology or degenerative disorder having potential to impair visual acuity
  • Pupil abnormality
  • Intraoperative cataract surgery complications that could affect IOL implantation or positioning

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Change in monocular best corrected distance visual acuity3 months postoperative

Best-corrected distance visual acuity as measured using an early-treatment diabetic retinopathy study (ETDRS) eye chart

Secondary Outcome Measures
NameTimeMethod
Change in monocular distance-corrected near visual acuity3 months postoperative

Distance-corrected distance visual acuity as measured using an early-treatment diabetic retinopathy study (ETDRS) eye chart

Trial Locations

Locations (1)

Dr Agarwal's Eye Hospital

🇮🇳

Chennai, Tamal Nadu, India

Dr Agarwal's Eye Hospital
🇮🇳Chennai, Tamal Nadu, India
Study Coordinator
Contact
044 4300 8800

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.